Irritable Bowel Syndrome with Diarrhea
📧 Sign up to get email alerts when something new happens for Irritable Bowel Syndrome with Diarrhea.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Efficacy of Eluxadoline in the Treatment of Irritable Bowel Syndrome With Diarrhea in Patients With Inadequate Control of Symptoms With Prior Loperamide Use [Phase 4]
Phase 4 trial evaluating eluxadoline for irritable bowel syndrome with diarrhea in patients with inadequate relief from prior loperamide; st…
-
CLINICAL_TRIALS trial_result · 2018-07-31Clinical Trial Update: Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of BEKINDA (Ondansetron 12 mg Bimodal Release Tablets) for Diarrhea Predominant Irritable Bowel Syndrome (IBS-D) [Phase 2]
Phase 2 randomized, double-blind trial evaluating BEKINDA (ondansetron 12 mg bimodal release) for diarrhea-predominant irritable bowel syndr…
-
CLINICAL_TRIALS trial_result · 2017-04-18Clinical Trial Update: Tong-Xie-Yao-Fang Granules for Diarrhea-predominant Irritable Bowel Syndrome [Phase 2, Phase 3]
Phase 2/3 trials of Tong-Xie-Yao-Fang Granules for diarrhea-predominant irritable bowel syndrome have completed.
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: Efficacy, Safety and Tolerability of DNK333 (25 mg Bid) in Women With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) [Phase 2]
A Phase 2 trial update reporting efficacy, safety and tolerability of DNK333 (25 mg twice daily) in women with diarrhea-predominant irritabl…
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: 52-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D) [Phase 3]
This Phase 3 52-week efficacy and safety study of ibodutant in women with irritable bowel syndrome with diarrhea was terminated, with result…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-09-27Clinical Trial Update: 12-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D) [Phase 3]
Phase 3 trial update showing 12-week efficacy and safety evaluation of ibodutant in women with irritable bowel syndrome with diarrhea; resul…
-
CLINICAL_TRIALS trial_result · 2016-09-05Clinical Trial Update: Therapeutic Effect of Chang'an I Recipe on Irritable Bowel Syndrome With Diarrhea [Phase 1, Phase 2]
Phase 1/Phase 2 trial results evaluating the Chang'an I Recipe for irritable bowel syndrome with diarrhea.
-
CLINICAL_TRIALS trial_result · 2015-10-12Clinical Trial Update: A Study to Assess the Efficacy and Safety of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS) [Phase 3]
A Phase 3 study evaluating YM060 for efficacy and safety in female patients with diarrhea-predominant irritable bowel syndrome has completed…
-
CLINICAL_TRIALS trial_result · 2015-07-08Clinical Trial Update: Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study [Phase 3]
This entry reports a Phase 3 trial evaluating rifaximin re-treatment for irritable bowel syndrome with diarrhea and notes that results were …
-
CLINICAL_TRIALS trial_result · 2013-04-26Clinical Trial Update: Post-Infectious Irritable Bowel Syndrome (PI-IBS)
A completed clinical trial update on post-infectious irritable bowel syndrome (PI-IBS), focusing on the diarrhea-predominant form.
-
CLINICAL_TRIALS trial_result · 2013-03-25Clinical Trial Update: Ibodutant for Relief of Irritable Bowel Syndrome With Diarrhoea (IBS-D) [Phase 2]
Phase 2 study of ibodutant for irritable bowel syndrome with diarrhea has completed, and results were posted in 2013. The sponsor/manufactur…
-
CLINICAL_TRIALS trial_result · 2012-09-27Clinical Trial Update: Mesalamine Granules for Irritable Bowel Syndrome (IBS) With Diarrhea [Phase 2]
Phase 2 clinical trial update for mesalamine granules in irritable bowel syndrome with diarrhea has completed with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-01-24Clinical Trial Update: Ondansetron for the Treatment of IBS With Diarrhoea (IBS-D) [Phase 4]
Phase 4 trial investigating ondansetron for irritable bowel syndrome with diarrhea has been completed.
-
CLINICAL_TRIALS trial_result · 2009-06-11Clinical Trial Update: Efficacy Study of Rezular (Arverapamil) in the Treatment of Irritable Bowel Syndrome With Diarrhea (IBS-D) [Phase 3]
Phase 3 efficacy study of Rezular (Arverapamil) for irritable bowel syndrome with diarrhea has completed.